Population pharmacokinetics of the angiogenesis inhibitor E7820 in patients with solid tumour or lymphoma

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	736-737
Number of pages	2
Journal	British Journal of Clinical Pharmacology
Volume	66
Issue number	5
Publication status	Published - 2008

ISI:000260498700030

Cite this

@article{09fdb393f30a491da014356abb4a74b4,

title = "Population pharmacokinetics of the angiogenesis inhibitor E7820 in patients with solid tumour or lymphoma",

author = "R.J. Keizer and M.K. Zamacona and M. Jansen and J. Wanders and J.H. Beijnen and J.H.M. Schellens and A.D.R. Huitema",

note = "ISI:000260498700030",

year = "2008",

language = "Undefined/Unknown",

volume = "66",

pages = "736--737",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "5",

}

TY - JOUR

T1 - Population pharmacokinetics of the angiogenesis inhibitor E7820 in patients with solid tumour or lymphoma

AU - Keizer, R.J.

AU - Zamacona, M.K.

AU - Jansen, M.

AU - Wanders, J.

AU - Beijnen, J.H.

AU - Schellens, J.H.M.

AU - Huitema, A.D.R.

N1 - ISI:000260498700030

PY - 2008

Y1 - 2008

M3 - Article

SN - 0306-5251

VL - 66

SP - 736

EP - 737

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

IS - 5

ER -